General Discussion
In reply to the discussion: Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?' [View all]Farmer-Rick
(12,720 posts)Suffer needless diseases in order to get them to pay for continued therapy for those injuries caused by those diseases is that they die.
The unvaccinated masses will eventually die from a lot of those diseases they let spread. So, no more money for the corporation. Dead people don't pay bills.
And of course the diseases mutate and develope resistance as they spread. And then low and behold, the CEOs and their families catch the newly evolved disease that are resistant to their vaccines.
Diseases have a funny way of getting around antibiotics and vaccines when they are allowed to spread continually and are exposed to the vaccines or antibiotics. Perfect recipe for evolving supper diseases like we have evolved antibiotic resistant bacteria thanks to the excessive use of antibiotics.